Is RGRX or PEP a better dividend investment in 2026?

RGRX currently yields 666666.67% with a 5% 5-year dividend growth rate. PEP yields 3.69% with 6.7% growth. The better choice depends on your goal: RGRX offers higher current income.

What is the dividend yield difference between RGRX and PEP?

RGRX has a forward dividend yield of 666666.67% ($2.00/share annually). PEP yields 3.69% ($5.42/share annually). The yield gap is 666662.98 percentage points.

Home › Compare › RGRX vs PEP

RGRX vs PEP: Dividend Comparison 2026

RGRX yields 666666.67% · PEP yields 3.69%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RGRX wins by $8.275235618773884e+34M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RGRX

● Live price

666666.67%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.275235618773884e+34M

Annual income

$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00

Full RGRX calculator →

PEP

PepsiCo Inc.

● Live price

3.69%

Share price

$146.80

Annual div

$5.42

5Y div CAGR

6.7%

Payout ratio

72%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.5K

Annual income

$1,034.52

Full PEP calculator →

Portfolio growth — RGRX vs PEP

📍 RGRX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RGRX	PEP
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RGRX + PEP cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RGRX pays

PEP pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RGRX

Annual income on $10K today (after 15% tax)

$56,666,666.67/yr

After 10yr DRIP, annual income (after tax)

$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr

PEP

Annual income on $10K today (after 15% tax)

$313.83/yr

After 10yr DRIP, annual income (after tax)

$879.34/yr

At 15% tax rate, RGRX beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RGRX + PEP for your $10,000?

RGRX: 50%PEP: 50%

100% PEP50/50100% RGRX

Portfolio after 10yr

$4.137617809386942e+34M

Annual income

$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.97%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

RGRX

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-878.3

Piotroski

4/9

PEP

Analyst Ratings

Strong

Buy

Hold

Sell

Consensus: Hold

Price Target

$172.43

+17.5% upside vs current

Range: $156.00 — $191.00

Altman Z

3.6

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RGRX buys

PEP buys

No recent congressional trades found for RGRX or PEP in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRGRXPEP

Forward yield	666666.67% ✓	3.69%
Annual dividend / share	$2.00	$5.42 ✓
Payout ratio	50% ✓	72%
1-year div growth	0%	7.1% ✓
5-year div CAGR	0%	6.7% ✓
Portfolio after 10y	$8.275235618773884e+34M	$21.5K ✓
Annual income after 10y	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00 ✓	$1,034.52
Total dividends collected	$8.275075881065991e+34M ✓	$6.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples
Analyst consensus	Buy	Hold

Year-by-year: RGRX vs PEP ($10,000, DRIP)

Year	RGRX Portfolio	RGRX Income/yr	PEP Portfolio	PEP Income/yr	Gap
1← crossover	$66,677,367	$66,666,666.67	$10,734	$393.95	+$66.67M → RGRX
2	$415,506,651,117	$415,435,306,334.37	$11,535	$436.36	+$415506.64M → RGRX
3	$2,419,908,598,386,268	$2,419,464,006,269,573.00	$12,411	$483.90	+$2419908598.37M → RGRX
4	$13,171,697,643,084,456,000	$13,169,108,340,884,183,000.00	$13,371	$537.26	+$13171697643084.44M → RGRX
5	$67,004,927,492,790,120,000,000	$66,990,833,776,312,020,000,000.00	$14,422	$597.26	+$67004927492790120.00M → RGRX
6	$318,562,277,003,514,840,000,000,000	$318,490,581,731,097,560,000,000,000.00	$15,578	$664.81	+$318562277003514871808.00M → RGRX
7	$1,415,484,168,853,553,000,000,000,000,000	$1,415,143,307,217,159,200,000,000,000,000.00	$16,848	$740.97	+$1.415484168853553e+24M → RGRX
8	$5,878,130,573,362,507,000,000,000,000,000,000	$5,876,616,005,301,833,000,000,000,000,000,000.00	$18,248	$826.99	+$5.878130573362507e+27M → RGRX
9	$22,813,793,009,840,743,000,000,000,000,000,000,000	$22,807,503,410,127,248,000,000,000,000,000,000,000.00	$19,793	$924.28	+$2.2813793009840744e+31M → RGRX
10	$82,752,356,187,738,840,000,000,000,000,000,000,000,000	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00	$21,500	$1,034.52	+$8.275235618773884e+34M → RGRX

RGRX vs PEP: Complete Analysis 2026

RGRX — Stock

RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland.

Full RGRX Calculator →

PEP — Consumer Staples

PepsiCo is a Dividend King with 52+ consecutive years of increases. Its diversified portfolio spans beverages and snacks via brands including Pepsi, Gatorade, Lay's, and Quaker. Snack food exposure provides more stable volumes than pure beverages. International expansion in emerging markets drives long-term growth.

Full PEP Calculator →

📬

Get this RGRX vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RGRX vs SCHD RGRX vs JEPI RGRX vs O RGRX vs KO RGRX vs MAIN RGRX vs MO RGRX vs PM RGRX vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.